Harmony Biosciences Holdings, Inc. – NASDAQ:HRMY

Add to watchlist

$36.75

+2.54

+7.46%

Market closed

Open in 2 days

+1.33%

month

+1.33%

quarter

+3.73%

year

Market Cap	1.94B
Enterprise value	1.83B

P/E	10.85
EV/Sales	4.18
EV/EBITDA	12.74
Price/Sales	4.30
Price/Book	4.67
PEG ratio	0.02
EPS	2.35

Revenue	617.51M
EBITDA	236.88M
Income	137.70M
Revenue Q/Q	29.79%
Revenue Y/Y	30.92%

Profit margin	41.44%
Oper. margin	27.45%
Gross margin	80.93%
EBIT margin	27.45%
EBITDA margin	38.36%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Harmony Biosciences Holdings Stock Forecast

M Q Y

Last Year

$44.5

Potential upside: 21.08%

Analysts Price target
Financials & Ratios estimates

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Profit margin
Jun 2023	134.21M	34.3M	25.56%
Sep 2023	160.26M	38.46M	24%
Dec 2023	168.41M	26.60M	15.8%
Mar 2024	154.61M	38.33M	24.79%

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Debt to assets
Jun 2023	760183000	275.01M	36.18%
Sep 2023	777766000	296.43M	38.11%
Dec 2023	811448000	344.45M	42.45%
Mar 2024	846985000	331.59M	39.15%

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Cash Flow
Jun 2023	37.06M	-7.77M	-339K
Sep 2023	63.1M	-813K	-55.09M
Dec 2023	76.66M	-36.06M	-53.52M
Mar 2024	31.14M	-6.18M	-3.63M

Harmony Biosciences Holdings alternative data

Harmony Biosciences Holdings
Employees

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Employee count
Aug 2023	200
Sep 2023	200
Oct 2023	200
Nov 2023	200
Dec 2023	200
Jan 2024	200
Feb 2024	200
Mar 2024	246
Apr 2024	246
May 2024	246
Jun 2024	246
Jul 2024	246

Harmony Biosciences Holdings
Hedge Funds Holdings Q3 2022

78.47% -0.88%

of HRMY is owned by hedge funds

181 +7

hedge funds hold HRMY stock

47.80M -269.98K

shares is hold by hedge funds

HRMY hedge funds holdings changes

Harmony Biosciences Holdings
Insider Trading

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Insider trades (number of shares)
Period	Buy	Sel
Mar 2024	0	12173

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Option	29 Mar 2024	KAPADIA SANDIP officer: CHIEF FINANCIAL OFFICER officer: CHIEF FINANCIAL OFFICER	Common Stock	15,000	N/A	N/A
Option	29 Mar 2024	KAPADIA SANDIP officer: CHIEF FINANCIAL OFFICER officer: CHIEF FINANCIAL OFFICER	Restricted Stock Units	15,000	N/A	N/A
Option	15 Mar 2024	DIERKS JEFFREY officer: CHIEF COMMERCIAL OFFICER officer: CHIEF COMMERCIAL OFFICER	Common Stock	11,979	$8.22	$98,467
Option	15 Mar 2024	DIERKS JEFFREY officer: CHIEF COMMERCIAL OFFICER officer: CHIEF COMMERCIAL OFFICER	Stock Option	9,644	$8.22	$79,274
Sale	15 Mar 2024	DIERKS JEFFREY officer: CHIEF COMMERCIAL OFFICER officer: CHIEF COMMERCIAL OFFICER	Common Stock	11,979	$32	$383,328
Option	15 Mar 2024	DIERKS JEFFREY officer: CHIEF COMMERCIAL OFFICER officer: CHIEF COMMERCIAL OFFICER	Stock Option	2,335	$8.22	$19,194
Option	8 Mar 2024	DIERKS JEFFREY officer: CHIEF COMMERCIAL OFFICER officer: CHIEF COMMERCIAL OFFICER	Stock Option	94	$8.22	$773
Option	8 Mar 2024	DIERKS JEFFREY officer: CHIEF COMMERCIAL OFFICER officer: CHIEF COMMERCIAL OFFICER	Stock Option	100	$8.22	$822
Option	8 Mar 2024	DIERKS JEFFREY officer: CHIEF COMMERCIAL OFFICER officer: CHIEF COMMERCIAL OFFICER	Common Stock	194	$8.22	$1,595
Sale	8 Mar 2024	DIERKS JEFFREY officer: CHIEF COMMERCIAL OFFICER officer: CHIEF COMMERCIAL OFFICER	Common Stock	194	$32	$6,208

HRMY insider trading transactions

Harmony Biosciences Holdings
Earnings Call Transcripts

Quarter	Transcript
Q1 2024 30 Apr 2024	Q1 2024 Earnings Call Transcript
Q4 2023 22 Feb 2024	Q4 2023 Earnings Call Transcript
Q3 2023 1 Nov 2023	Q3 2023 Earnings Call Transcript
Q2 2023 1 Aug 2023	Q2 2023 Earnings Call Transcript

HRMY earnings call transcripts

Harmony Biosciences Holdings
Executives

Insider	Age	Compensation
Mr. John Charles Jacobs M.B.A. (1967) Pres, Chief Executive Officer & Director	58	$933,940
Dr. Jeffrey M. Dayno M.D. (1957) Chief Medical Officer	68	$734,250
Mr. Jeffrey Dierks M.B.A. (1971) Chief Commercial Officer	54	$482,450
Mr. Jeffrey S. Aronin (1968) Founder & Non-Executive Chairman	57	$31,200

Harmony Biosciences Holdings
Latest News

Friday, 20 December 2024
07:25	Levi & Korsinsky Announces an Investigation on Behalf of Harmony Biosciences Holdings, Inc. (HRMY) Shareholders Who May Have Been Affected by Fraud	accesswire.com
Thursday, 19 December 2024
07:25	Lost Money on Harmony Biosciences Holdings, Inc.(HRMY)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky	accesswire.com
Wednesday, 18 December 2024
08:05	HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE	prnewswire.com
07:30	Lost Money on Harmony Biosciences Holdings, Inc.(HRMY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation	accesswire.com
Tuesday, 17 December 2024
07:25	Investors who lost money on Harmony Biosciences Holdings, Inc. should contact Levi & Korsinsky about an ongoing investigation - HRMY	accesswire.com
Monday, 16 December 2024
07:25	Harmony Biosciences Holdings, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - HRMY	accesswire.com
Friday, 13 December 2024
07:30	HRMY ALERT - Levi & Korsinsky Has Commenced an Investigation on Behalf of Harmony Biosciences Holdings, Inc. Shareholders Who Lost Money	accesswire.com
Thursday, 12 December 2024
07:25	Harmony Biosciences Holdings, Inc. Being Investigated on Behalf of Harmony Biosciences Holdings, Inc. Investors. Contact Levi & Korsinsky For Details.	accesswire.com
Wednesday, 11 December 2024
07:25	Levi & Korsinsky Investigates Possible Securities Fraud Violations by Harmony Biosciences Holdings, Inc. (HRMY)	accesswire.com
Tuesday, 10 December 2024
07:30	Did Harmony Biosciences Holdings, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - HRMY	accesswire.com
Monday, 9 December 2024
07:30	Lost Money on Harmony Biosciences Holdings, Inc. (HRMY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation	accesswire.com
Friday, 6 December 2024
07:30	Levi & Korsinsky Investigates Possible Securities Fraud Violations by Harmony Biosciences Holdings, Inc. (HRMY)	accesswire.com
Thursday, 5 December 2024
07:25	Lost Money on Harmony Biosciences Holdings, Inc.(HRMY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation	accesswire.com
Wednesday, 4 December 2024
07:25	Harmony Biosciences Holdings, Inc. (HRMY) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates	accesswire.com
Tuesday, 3 December 2024
08:05	HARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMIT	prnewswire.com
Friday, 29 November 2024
08:00	HRMY STOCK ALERT: Levi & Korsinsky Notifies Harmony Biosciences Holdings, Inc. Investors of an Ongoing Investigation	accesswire.com
Tuesday, 26 November 2024
07:25	ATTENTION HRMY SHAREHOLDERS: Investors who lost money on Harmony Biosciences Holdings, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation	accesswire.com
Monday, 25 November 2024
07:30	Harmony Biosciences Holdings, Inc. (HRMY) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights	accesswire.com
Thursday, 21 November 2024
08:05	HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES	prnewswire.com
07:25	ATTENTION Harmony Biosciences Holdings, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights	accesswire.com
Wednesday, 20 November 2024
07:30	Harmony Biosciences Holdings, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - HRMY	accesswire.com
Tuesday, 19 November 2024
07:30	HRMY ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Harmony Biosciences Holdings, Inc. Shareholders Who Lost Money	accesswire.com
Monday, 18 November 2024
07:25	HRMY ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Harmony Biosciences Holdings, Inc.	accesswire.com
Friday, 15 November 2024
07:30	Shareholders that lost money on Harmony Biosciences Holdings, Inc. (HRMY) should contact Levi & Korsinsky about Securities Fraud Investigation - HRMY	accesswire.com
Thursday, 14 November 2024
07:25	ATTENTION Harmony Biosciences Holdings, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights	accesswire.com
Wednesday, 13 November 2024
07:25	An Investigation Has Commenced on Behalf of Harmony Biosciences Holdings, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your HRMY Losses.	accesswire.com
Tuesday, 12 November 2024
07:30	Harmony Biosciences Holdings, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - HRMY	accesswire.com
Monday, 11 November 2024
16:57	Harmony Biosciences: sNDA Of WAKIX Brings Additional Value Inflection Points	seekingalpha.com
07:30	An Investigation Has Commenced on Behalf of Harmony Biosciences Holdings, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your HRMY Losses	accesswire.com
Friday, 8 November 2024
07:30	Harmony Biosciences Holdings, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - HRMY	accesswire.com

Ideas & Opinions

Seeking Alpha 24 Jan 2025

Harmony Biosciences: Don't Sleep On This Enterprising, Profitable Biotech
Seeking Alpha 26 Jan 2024

Alkermes: Additional Narcolepsy Data Could Lead The Way To The Next Stage
Seeking Alpha 13 Oct 2023

Harmony Stock Tanks On Study Miss For Narcolepsy Drug: Problems May Be Escalating
Seeking Alpha 11 Oct 2023

Amphastar Pharmaceuticals: Great Growth At A High Price
Seeking Alpha 24 Sep 2023

Harmony Biosciences: A Balancing Act As Investors Lose Some Sleep
Seeking Alpha 27 Jul 2023

Harmony Biosciences: Rare Low-Volume Accumulation With Short Squeeze Potential
Seeking Alpha 24 May 2023

Harmony Biosciences: A Company With Solid Fundamentals (Rating Upgrade)
Seeking Alpha 12 Mar 2023

Avadel Pharmaceuticals: Real-World Data Supports Market Opportunity For Lumryz
Seeking Alpha 12 Mar 2023

Harmony Biosciences: Why I Am Adding More Shares
Seeking Alpha 14 Dec 2022

Harmony Biosciences: Up 40% Since My Last Coverage, Waiting For Another Opportunity

Frequently Asked Questions (FAQ)

What's the price of Harmony Biosciences Holdings stock today?

One share of Harmony Biosciences Holdings stock can currently be purchased for approximately $36.75.
When is Harmony Biosciences Holdings's next earnings date?

Unfortunately, Harmony Biosciences Holdings's (HRMY) next earnings date is currently unknown.
Does Harmony Biosciences Holdings pay dividends?

No, Harmony Biosciences Holdings does not pay dividends.
How much money does Harmony Biosciences Holdings make?

Harmony Biosciences Holdings has a market capitalization of 1.94B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 32.93% to 582.02M US dollars.
What is Harmony Biosciences Holdings's stock symbol?

Harmony Biosciences Holdings, Inc. is traded on the NASDAQ under the ticker symbol "HRMY".
What is Harmony Biosciences Holdings's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Harmony Biosciences Holdings?

Shares of Harmony Biosciences Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Harmony Biosciences Holdings's key executives?
Harmony Biosciences Holdings's management team includes the following people:
- Mr. John Charles Jacobs M.B.A. Pres, Chief Executive Officer & Director(age: 58, pay: $933,940)
- Dr. Jeffrey M. Dayno M.D. Chief Medical Officer(age: 68, pay: $734,250)
- Mr. Jeffrey Dierks M.B.A. Chief Commercial Officer(age: 54, pay: $482,450)
- Mr. Jeffrey S. Aronin Founder & Non-Executive Chairman(age: 57, pay: $31,200)
Is Harmony Biosciences Holdings founder-led company?

Yes, Harmony Biosciences Holdings is a company led by its founder Mr. Jeffrey S. Aronin.
How many employees does Harmony Biosciences Holdings have?

As Jul 2024, Harmony Biosciences Holdings employs 246 workers.
When Harmony Biosciences Holdings went public?

Harmony Biosciences Holdings, Inc. is publicly traded company for more then 5 years since IPO on 19 Aug 2020.
What is Harmony Biosciences Holdings's official website?

The official website for Harmony Biosciences Holdings is harmonybiosciences.com.
Where are Harmony Biosciences Holdings's headquarters?

Harmony Biosciences Holdings is headquartered at 630 West Germantown Pike, Plymouth Meeting, PA.
How can i contact Harmony Biosciences Holdings?

Harmony Biosciences Holdings's mailing address is 630 West Germantown Pike, Plymouth Meeting, PA and company can be reached via phone at +48 45399800.
What is Harmony Biosciences Holdings stock forecast & price target?

Based on 3 Wall Street analysts` predicted price targets for Harmony Biosciences Holdings in the last 12 months, the avarage price target is $44.5. The average price target represents a 21.08% change from the last price of $36.75.

Harmony Biosciences Holdings, Inc.

harmonybiosciences.com

Exchange:

NASDAQ

Full time employees:

246

Industry:

Biotechnology

Sector:

Healthcare

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.

+48 45399800

630 West Germantown Pike
Plymouth Meeting, PA 19462

CIK: 0001802665
ISIN: US4131971040
CUSIP: 413197104